Features Production
Freedom Cannabis receives Health Canada licenses

The company has also announced the concurrent receipt of its licence to sell cannabis for medical purposes.

“Receiving our cultivation licence and medicinal sales licence together is a major milestone for Freedom,” said Ed Bereznicki, Freedom’s lead advisor. “The team is preparing to plant the first harvest in the coming weeks and will initially produce high quality flower and extracts in anticipation of servicing the demands of the medicinal and adult use cannabis markets in Canada and abroad.”

Freedom said its “commercial scale/craft quality” strategy utilizes smaller gardening areas and small batch cultivation techniques to mitigate risk and improve yields and quality. The company believes this growing methodology, combined with its large and diverse genetics portfolio, will enable Freedom to offer a variety of high-quality cannabis products.

With the successful licensing of Phase 1, Freedom said it expects to produce more than 3,000 kilograms of dry cannabis per year.  Freedom’s first harvest, including its compulsory test crops, is expected to occur in approximately four months.

Following the successful start-up of Phase 1, Freedom will continue with the buildout of Phase 2 of its 126,000 square foot (total) indoor grow facility. Located entirely within the existing building envelope, Phase 2 is expected to add an additional 12,000 kilograms per year of production capacity. In addition, construction of Freedom’s laboratory facilities will continue, including extraction, analytics and R&D.